List view / Grid view
21 June 2017 | By Charles River Laboratories
Peer-reviewed paper on how touchscreen testing is a translational tool to assess cognitive function in a mouse model of Alzheimer’s disease...
19 June 2017 | By Niamh Marriott (Drug Target Review)
AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.
16 June 2017 | By Niamh Marriott (Drug Target Review)
The ABPI has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.
14 June 2017 | By Niamh Marriott (Drug Target Review)
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
12 June 2017 | By Niamh Marriott (Drug Target Review)
Artificial intelligence can be used to recognise difficult to predict complications as early as possible within the home care of heart patients.
9 June 2017 | By Enda O’Connell (National University of Ireland Galway), Howard Fearnhead (National University of Ireland Galway), Markus Wolf (Fraunhofer-IME SP), Sheraz Gul (Fraunhofer-IME SP)
In this application note, Sheraz Gul (Fraunhofer-IME SP), Markus Wolf (Fraunhofer-IME SP), Enda O’Connell (National University of Ireland Galway) and Howard Fearnhead (National University of Ireland Galway), demonstrate that the Echo 550 Liquid Handler can precisely and accurately transfer nanolitre volumes of compound with acoustic energy in a completely contact-free…
9 June 2017 | By Adyary Fallarero (Thermo Fisher Scientific), Sheraz Gul (Fraunhofer-IME SP)
This application note describes how to perform a cell viability assay using the Thermo Scientific Varioskan LUX multimode microplate reader and the Thermo Scientific Multidrop Combi reagent dispenser...
8 June 2017 | By Niamh Marriott (Drug Target Review)
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.
7 June 2017 | By Charles River Laboratories
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
2 June 2017 | By Carol V Robinson, Hsin-Yung Yen, Idlir Liko, Jonathan ST Hopper, Timothy Allison
Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.
2 June 2017 | By Niamh Marriott (Drug Target Review)
The Chan Zuckerberg Initiative announced financial support for the Human Cell Atlas, which uses sequencing technology to redefine every cell in the body...
1 June 2017 | By Niamh Marriott (Drug Target Review)
SOPHiA AI demystifies the secrets of the exome, home to 85% of disease-causing genetic variants. Clinicians can now get highly accurate results to diagnose patients for rare hereditary disorders.
30 May 2017 | By Niamh Marriott (Drug Target Review)
As CRISPR-Cas9 starts to move into clinical trials, a new study has found that the gene-editing technology can introduce hundreds of unintended mutations into the genome.
25 May 2017 | By Sarah Wills (Drug Target Review)
Researchers at the Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
25 May 2017 | By Niamh Marriott (Drug Target Review)
Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field.
Send this to a friend
Follow: